OTCMKTS:PBIOPressure Biosciences Stock Price, Forecast & News

$2.13

-0.02 (-0.93 %)

(As of 07/3/2020 04:00 PM ET)

Add

Compare

Today's Range

$1.99

Now: $2.13▼

$2.20

50-Day Range

$2.15

MA: $2.58▼

$3.88

52-Week Range

$0.60

Now: $2.13▼

$4.49

Volume10,596 shs

Average Volume15,772 shs

Market Capitalization$6.73 million

P/E RatioN/A

Dividend YieldN/A

Beta1.08

Pressure BioSciences, Inc. develops pressure cycling technology (PCT) solutions. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations, including Barocycler 2320EXT, Barozyme-HT48, Barocycler NEP3229, HUB440, HUB880, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT-MicroCaps, PCT-Micro-Pestle, PULSE Tubes, and BaroFlex 8-well Processing Strips, as well as application specific kits. Pressure BioSciences, Inc. serves researchers at academic laboratories; government agencies; and biotechnology, pharmaceutical, and other life sciences institutions in the United States, Europe, and Asia. Pressure BioSciences, Inc. has a collaboration with NutraFuels, Inc. for the development of water-soluble Nanoemulsion-based nutraceuticals. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was founded in 1978 and is based in South Easton, Massachusetts.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Pressure Biosciences.

2.2 Community Rank

Outperform Votes
Pressure Biosciences has received 82 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Pressure Biosciences has received 102 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Pressure Biosciences has received 55.43% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Pressure Biosciences and other stocks. Vote “Outperform” if you believe PBIO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Pressure Biosciences does not currently pay a dividend.
Dividend Growth
Pressure Biosciences does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Pressure Biosciences insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 17.05% of the stock of Pressure Biosciences is held by insiders.
Percentage Held by Institutions
Only 0.01% of the stock of Pressure Biosciences is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Pressure Biosciences are expected to grow in the coming year, from ($3.50) to ($2.09) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Pressure Biosciences is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Pressure Biosciences is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Overall Beat the Market Rank^™

0.57 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Analytical instruments

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:PBIO

Previous Symbol

CUSIPN/A

CIK830656

Webwww.pressurebiosciences.com

Phone508-230-1828

Debt

Debt-to-Equity RatioN/A

Current Ratio0.08

Quick Ratio0.03

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$1.81 million

Price / Sales3.72

Cash FlowN/A

Price / Cash FlowN/A

Book Value($13.00) per share

Price / Book-0.16

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-11,660,000.00

Net Margins-644.25%

Return on EquityN/A

Return on Assets-519.54%

Miscellaneous

Employees17

Outstanding Shares3,160,000

Market Cap$6.73 million

Next Earnings Date8/20/2020 (Estimated)

OptionableNot Optionable

Receive PBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for PBIO and its competitors with MarketBeat's FREE daily newsletter.

Pressure Biosciences (OTCMKTS:PBIO) Frequently Asked Questions

How has Pressure Biosciences' stock been impacted by COVID-19 (Coronavirus)?

Pressure Biosciences' stock was trading at $2.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PBIO shares have increased by 6.5% and is now trading at $2.13. View which stocks have been most impacted by Coronavirus.

When is Pressure Biosciences' next earnings date?

Pressure Biosciences is scheduled to release its next quarterly earnings announcement on Thursday, August 20th 2020. View our earnings forecast for Pressure Biosciences.

How were Pressure Biosciences' earnings last quarter?

Pressure Biosciences Inc (OTCMKTS:PBIO) announced its earnings results on Tuesday, May, 15th. The company reported ($1.64) EPS for the quarter. The company had revenue of $0.61 million for the quarter. View Pressure Biosciences' earnings history.

Has Pressure Biosciences been receiving favorable news coverage?

Media headlines about PBIO stock have trended somewhat negative this week, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Pressure Biosciences earned a news sentiment score of -1.3 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news about Pressure Biosciences.

Who are some of Pressure Biosciences' key competitors?

Some companies that are related to Pressure Biosciences include Aethlon Medical (AEMD), Precipio (PRPO), Scientific Industries (SCND), Arrayit (ARYC) and PositiveID (PSID). View all competitors.

What other stocks do shareholders of Pressure Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pressure Biosciences investors own include Monaker Group (MKGI), Advanced Micro Devices (AMD), Allena Pharmaceuticals (ALNA), Actinium Pharmaceuticals (ATNM), Anavex Life Sciences (AVXL), Aware (AWRE), Curaleaf (CURLF), Walt Disney (DIS), Green Thumb Industries (GTBIF) and InterCloud Systems (ICLD).

Who are Pressure Biosciences' key executives?

Pressure Biosciences' management team includes the following people:

Mr. Richard T. Schumacher, Founder, Pres, CEO, Treasurer, Clerk, Sec. & Director (Age 69)
Dr. Alexander V. Lazarev, Chief Science Officer (Age 54)
Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D., Sr. VP of Engineering (Age 64)
Mr. Richard P. Thomley, Acting Chief Financial Officer (Age 67)
Dr. Bradford Addison Young, Sr. VP & Chief Commercial Officer (Age 50)

What is Pressure Biosciences' stock symbol?

Pressure Biosciences trades on the OTCMKTS under the ticker symbol "PBIO."

How do I buy shares of Pressure Biosciences?

Shares of PBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pressure Biosciences' stock price today?

One share of PBIO stock can currently be purchased for approximately $2.13.

How big of a company is Pressure Biosciences?

Pressure Biosciences has a market capitalization of $6.73 million and generates $1.81 million in revenue each year. Pressure Biosciences employs 17 workers across the globe.

What is Pressure Biosciences' official website?

The official website for Pressure Biosciences is www.pressurebiosciences.com.

How can I contact Pressure Biosciences?

Pressure Biosciences' mailing address is 14 NORFOLK AVENUE, SOUTH EASTON MA, 02375. The company can be reached via phone at 508-230-1828 or via email at [email protected]

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings